Latest / Applied Clinical Trials
ACT Brief: Trial Representation and Design, CRO Revenue Recognition Risks, and Real-Time FDA Data Review
In today's ACT Brief, we examine how improving representation changes trial design at Merck, revenue recognition challenges in CRO contracts, and FDA's pilot program for real-time clinical data review.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.